Phase 1 study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancerT.W. Laetsch,R. Nagasubramanian,S.G. Dubois, L. Mascarenhas,D. Hawkins,N. Shukla,B. Turpin,S. Smith,M. Reynolds,S. Cruickshank,L. Donahue,M.C. Cox, A. PappoAnnals of Oncology(2016)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要